David T. Crandall, PhD
- 3Articles
- 5.8KReads
- 2007–2008Active
- 16Collaborators
- 35Citations
About
David T. Crandall, PhD, has published research on the clinical effects of aripiprazole in the treatment of schizophrenia, schizoaffective disorders, and bipolar disorder. His work includes analyses of aripiprazole's efficacy across symptom spectrums and its impact on agitation and antimanic response in acute phases of these conditions. His contributions appeared in Psychiatrist.com between 2007 and 2008.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
